Skip to content

Author

Hai-Ying Cui

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

HDAC inhibitors in cancer therapy: sensitization mechanisms, combination strategies, and translational challenges

Histone deacetylases (HDACs) are key regulators of chromatin architecture and gene expression, and their dysregulation is closely linked to tumorigenesis, making them attractive targets for cancer therapy. Histone deacetylase inhibitors (HDACis) exert broad antitumor effects by modulating both epigenetic and non-epigen...

Kun Liu, Xiang Zhao, Jia-Hui Liu et al. · 0 citations
Review Sep 2026

Prenylation: A key regulatory point in tumor metabolism and a potential therapeutic target.

Overall, protein prenylation represents a key regulatory hub linking signal transduction, metabolic reprogramming, and tumorigenesis, as well as advancing clinical translation through biomarker development and well-designed clinical trials.

Zhen-Jin Su, Fang-Ming Liu, Yi-Yu Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.